packageVestronidaseAlfa

vestronidase alfa

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vestronidase alfa is an enzyme replacement therapy used to treat mucopolysaccharidosis VII, also known as Sly syndrome. It is authorised in the European Union and is used mainly for this rare metabolic disorder.

Summary written by glm-5.3-flash from Wikidata Q48970976 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vestronidase alfa
ATC codes:A16AB18
DrugBank:DB12366
Wikidata:Q48970976
molar mass:72562 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown